Development of Smartphone-based Medication Management Application for Coronary Artery Disease
| Autor: | Peirong Wu, 吳佩蓉 |
|---|---|
| Rok vydání: | 2017 |
| Druh dokumentu: | 學位論文 ; thesis |
| Popis: | 105 Medication nonadherence of chronic disease has been taken seriously among worldwide health organization because medication nonadherence could lead to poor health outcome, waste of medical resources and increase in medical cost. Thus, find a way to solve the problem of medication nonadherence is worthy of further study. Among hundreds of chronic disease, heart disease has been the top ten of the leading cause of death in Taiwan for a long time; the mortality of heart disease rises up becoming the second high, only below cancer in this decade. In other country, for example, China, heart disease becomes the top three cause of death and the mortality of heart disease is high, too. There are many kinds of heart disease, the most common of all is the coronary artery disease. In the long-term treatment of coronary artery disease, a patient needs to take medication, does cardiac rehabilitation, be given proper health education, then the health outcome of the patient who suffers from coronary artery disease would turn well. Therefore, the researcher wants to improve the medication adherence of patients and improve their health outcome in an easy, convenient, low-cost way. The characteristics of the smartphone meet the needs of this study, the smartphone is convenient for carrying and the cost of mobile application development is much lower than that of other medical treatment. At the end of this study, the researcher developed a medication management system called ‘Drug Helper’ for patients who suffer from coronary artery disease. Drug Helper is a mobile application built on Android OS, available for Android version 4.1 or up; it is integrated with many functionalities (ex: medication reminder, medication record and health education about coronary artery disease). The division of cardiology of a tertiary hospital in Beijing, China did a clinical trial from September, 2016 to March, 2017 for evaluating the clinical value of Drug Helper. The results of this clinical trial show that the Morisky medication adherence scale score of control group is 3.20, and that of intervention group is 3.88; the rate of MACE of control group is 50.0%, and that of intervention group is 22.2%. According to the above results, both the medication adherence and the health outcome of intervention group are better than that of control group. Thus, this demonstrates that Drug Helper is useful to patients who suffer from coronary artery disease. |
| Databáze: | Networked Digital Library of Theses & Dissertations |
| Externí odkaz: |
|